US FDA rejects MS drug Lemtrada (alemtuzumab, Campath)

[agate]

According to a report in WebMD (January 3, 2013), the US FDA has rejected the MS drug Lemtrada, also known as alemtuzumab or Campath, because the benefits don't outweigh the risks.

The article is Only registered and activated users can see links., Click Here To Register....

[SalpalSally]

Thanks Agate. You don't thing the FDA is finally on our side as apposed to the Big Pharma's side do you? Could they be saying what we are saying..."come up with a cure and quit poisoning us with these under-achieving, money making, possible killer band aides. I hope so.

[SalpalSally]

Thanks Agate. You don't thing the FDA is finally on our side as apposed to the Big Pharma's side do you? Could they be saying what we are saying..."come up with a cure and quit poisoning us with these under-achieving, money making, possible killer band aides". I hope so.

[Frog42]

You don't thing the FDA is finally on our side as apposed to the Big Pharma's side do you?

I wish I could believe that, Sally, but I doubt it.

[agate]

Sally, it may be a case of "once bitten, twice shy." Maybe Big Pharma and the FDA have just learned a thing or two from experience with some of the other MS drugs. Maybe we were expected to be more willing to put up with the risks and the side effects than we turned out to be, and so now they're watching their backs more.

In a way, I've just been restating what you said. The FDA is probably a little less willing to OK every drug that comes along.

Interesting that in Europea, Canada and Australia Lemtrada is OK.

[Cherie]

High risk with this drug of auto-immune thyroiditis. Some of the clinical trial notes claim this to be as high as 30% after a couple of years of treatment. They are asking for another phase III trial against a drug known to be effective at reducing relapses.